Cargando…

Potential Therapeutic Strategies for Alzheimer's Disease Targeting or Beyond β-Amyloid: Insights from Clinical Trials

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with two hallmarks: β-amyloid plagues and neurofibrillary tangles. It is one of the most alarming illnesses to elderly people. No effective drugs and therapies have been developed, while mechanism-based explorations of therape...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Qiutian, Deng, Yulin, Qing, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124758/ https://www.ncbi.nlm.nih.gov/pubmed/25136630 http://dx.doi.org/10.1155/2014/837157

Ejemplares similares

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
por: Song, Chenghuan, et al.
Publicado: (2022)

Alzheimer’s disease beyond amyloid: strategies for future therapeutic interventions
por: Shi, Jiong, et al.
Publicado: (2020)

Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease
por: Dawkins, Edgar, et al.
Publicado: (2014)

Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer’s Disease
por: Yoon, Sang-Sun, et al.
Publicado: (2012)

Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease
por: Kim, Dong Eun, et al.
Publicado: (2020)

Alzheimer's Therapeutic Strategy: Photoactive Platforms for Suppressing the Aggregation of Amyloid β Protein
por: Li, Chenglong, et al.
Publicado: (2020)

Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer’s Disease
por: Menendez-Gonzalez, Manuel, et al.
Publicado: (2018)

Computational Study of Natural Compounds for the Clearance of Amyloid-Βeta: A Potential Therapeutic Management Strategy for Alzheimer’s Disease
por: Ahmad, Syed Sayeed, et al.
Publicado: (2019)

Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer’s Disease
por: Behl, Tapan, et al.
Publicado: (2020)

Sleep in Alzheimer's Disease–Beyond Amyloid
por: Holth, Jerrah K., et al.
Publicado: (2016)

The Therapeutic and Diagnostic Potential of Amyloid β Oligomers Selective Antibodies to Treat Alzheimer’s Disease
por: Viola, Kirsten L., et al.
Publicado: (2022)

β-Amyloid Degradation and Alzheimer's Disease
por: Wang, Deng-Shun, et al.
Publicado: (2006)

Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer’s disease
por: Madadi, Soheil, et al.
Publicado: (2019)

Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer's Disease Treatment: Rethinking the Current Strategy
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2012)

RAGE targeted strategies for Alzheimer’s amyloid β peptide induced blood brain barrier dysfunctions
por: Askarova, Sholpan, et al.
Publicado: (2013)

Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid
por: Yang, Ting, et al.
Publicado: (2019)

Alzheimer's Progenitor Amyloid‐β Targets and Dissolves Microbial Amyloids and Impairs Biofilm Function
por: Ali, Syed Aoun, et al.
Publicado: (2023)

Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer’s Disease Therapeutics
por: Jeong, Hyomin, et al.
Publicado: (2022)

Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease
por: Mantile, Francesca, et al.
Publicado: (2020)

Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer’s Disease
por: Tanaka, Masashi, et al.
Publicado: (2020)

Amyloid PET imaging: applications beyond Alzheimer’s disease
por: Catafau, Ana M., et al.
Publicado: (2015)

Beyond amyloid: New approaches to Alzheimer's disease treatment
Publicado: (2020)

Amyloid β and free heme: bloody new insights into the pathogenesis of Alzheimer’s disease
por: Flemmig, Jörg, et al.
Publicado: (2018)

Insights Into the Mechanism of Tyrosine Nitration in Preventing β-Amyloid Aggregation in Alzheimer’s Disease
por: Zhao, Jie, et al.
Publicado: (2021)

Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease
por: Jana, Ankit, et al.
Publicado: (2022)

Protein Interactome of Amyloid-β as a Therapeutic Target
por: Lazarev, Vladimir F., et al.
Publicado: (2023)

Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer’s Disease
por: Karisetty, Bhanu Chandra, et al.
Publicado: (2020)

Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer’s Disease
por: Campos-Peña, Victoria, et al.
Publicado: (2022)

Cellular response to β‐amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics
por: Zhang, Haolin, et al.
Publicado: (2023)

Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
por: Zakaria, Nur Atikah, et al.
Publicado: (2021)

Comparison of Tau and Amyloid-β Targeted Immunotherapy Nanoparticles for Alzheimer’s Disease
por: Mashal, Yara, et al.
Publicado: (2022)

Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2023)

Mitochondria, Amyloid β, and Alzheimer's Disease
por: Readnower, Ryan D., et al.
Publicado: (2011)

The Amyloid-β Pathway in Alzheimer’s Disease
por: Hampel, Harald, et al.
Publicado: (2021)

Sleep and β-Amyloid Deposition in Alzheimer Disease: Insights on Mechanisms and Possible Innovative Treatments
por: Cordone, Susanna, et al.
Publicado: (2019)

Interpreting Alzheimer’s disease clinical trials in light of the effects on amyloid-β
por: Toyn, Jeremy H, et al.
Publicado: (2014)

Interactions between Amyloid-β and Hemoglobin: Implications for Amyloid Plaque Formation in Alzheimer's Disease
por: Chuang, Jia-Ying, et al.
Publicado: (2012)

Calcium-Sensing Receptors of Human Astrocyte-Neuron Teams: Amyloid-β-Driven Mediators and Therapeutic Targets of Alzheimer’s Disease
por: Dal Prà, I, et al.
Publicado: (2014)

Riluzole: a therapeutic strategy in Alzheimer’s disease by targeting the WNT/β-catenin pathway
por: Vallée, Alexandre, et al.
Publicado: (2020)

Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model
por: Zhang, She-Qing, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dhg04e3p0qdnaj9tdtku8gvm6g